BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12834813)

  • 1. Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7.
    Wang D; Deng C; Bugaj-Gaweda B; Kwan M; Gunwaldsen C; Leonard C; Xin X; Hu Y; Unterbeck A; De Vivo M
    Cell Signal; 2003 Sep; 15(9):883-91. PubMed ID: 12834813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases.
    Richter W; Conti M
    J Biol Chem; 2004 Jul; 279(29):30338-48. PubMed ID: 15131123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene.
    Wallace DA; Johnston LA; Huston E; MacMaster D; Houslay TM; Cheung YF; Campbell L; Millen JE; Smith RA; Gall I; Knowles RG; Sullivan M; Houslay MD
    Mol Pharmacol; 2005 Jun; 67(6):1920-34. PubMed ID: 15738310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene.
    Bolger GB; Erdogan S; Jones RE; Loughney K; Scotland G; Hoffmann R; Wilkinson I; Farrell C; Houslay MD
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):539-48. PubMed ID: 9371713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.
    MacKenzie SJ; Houslay MD
    Biochem J; 2000 Apr; 347(Pt 2):571-8. PubMed ID: 10749688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
    Sasaki T; Kotera J; Omori K
    J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells.
    Stefan E; Wiesner B; Baillie GS; Mollajew R; Henn V; Lorenz D; Furkert J; Santamaria K; Nedvetsky P; Hundsrucker C; Beyermann M; Krause E; Pohl P; Gall I; MacIntyre AN; Bachmann S; Houslay MD; Rosenthal W; Klussmann E
    J Am Soc Nephrol; 2007 Jan; 18(1):199-212. PubMed ID: 17135396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10.
    Rena G; Begg F; Ross A; MacKenzie C; McPhee I; Campbell L; Huston E; Sullivan M; Houslay MD
    Mol Pharmacol; 2001 May; 59(5):996-1011. PubMed ID: 11306681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
    Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
    Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation.
    Sasaki T; Kotera J; Omori K
    Biochem J; 2002 Jan; 361(Pt 2):211-20. PubMed ID: 11772393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
    Cherry JA; Thompson BE; Pho V
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
    Huston E; Lumb S; Russell A; Catterall C; Ross AH; Steele MR; Bolger GB; Perry MJ; Owens RJ; Houslay MD
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions.
    Beard MB; Olsen AE; Jones RE; Erdogan S; Houslay MD; Bolger GB
    J Biol Chem; 2000 Apr; 275(14):10349-58. PubMed ID: 10744723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.
    D'Sa C; Tolbert LM; Conti M; Duman RS
    J Neurochem; 2002 May; 81(4):745-57. PubMed ID: 12065634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
    Terry R; Cheung YF; Praestegaard M; Baillie GS; Huston E; Gall I; Adams DR; Houslay MD
    Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
    He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
    Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.
    Henderson DJ; Byrne A; Dulla K; Jenster G; Hoffmann R; Baillie GS; Houslay MD
    Br J Cancer; 2014 Mar; 110(5):1278-87. PubMed ID: 24518597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.